Quantum Genomics Corp.(QGC) is a global Biotechnology company maximizing the developments and discoveries of academic research into breakthrough treatments for human disease.

QGC has unique expertise in the detection and selection of highly promising life science technology projects.

QGC co-develops products with academic teams, premier Biotech research entities, and some of the world's leading pharmaceutical and bio-science companies.

QGC's strategic alliances and business partnerships range from disease-oriented therapeutic collaborations, technology transfer-agreements, and marketing/licensing agreements, in the fields of recombinant proteins, monoclonal antibodies, and advanced chemical compounds.

QGC develops public/private partnerships to expedite the process of translational research and development, evolving life-science research into market products and therapies.